Jaya Biosciences Joins Taking the Pulse - A Health Care and Life Sciences Podcast

Written By Pawel Krysiak
Listen to the podcast

August 12, 2025

Our CEO Pawel Krysiak and CSO Neal Goodwin, PhD, joined Taking the Pulse - A Health Care and Life Sciences Podcast to discuss JayaBio’s work in a precision medicine platform aiming to stop progression in Alzheimer’s, Parkinson’s, and frontotemporal dementia.

They share how the team is using precision medicine to target specific mutations linked to Alzheimer’s, Parkinson’s, and frontotemporal dementia, aiming to arrest disease progression with a single dose. The conversation explores how gene therapy works, what makes JayaBio’s approach different, and more.

Pawel Krysiak
Previous

Jaya Biosciences Receives U.S. Patent for Novel Methods of Treating Neurological Diseases, Including Alzheimer’s Disease, Expanding its Global Intellectual Property Portfolio
Next

Jaya Biosciences Receives Patent Notices of Allowance in Japan, China, and Singapore for Novel Methods of Treating Neurological Diseases, including Alzheimer’s